India Merger Acquisition MCA Regulatory Filings — August 18, 2026

18-08-2026

Crest Ventures Limited informed exchanges that its wholly owned subsidiary Crest EZY Living Private Limited has incorporated two step-down wholly owned subsidiaries: EZY Living Nest Private Limited (incorporated August 17, 2026) and EZY Living Spaces Private Limited (incorporated August 18, 2026). The new entities are yet to commence business operations and aim to undertake real estate development, including rental housing assets like build-to-rent, co-living, and student housing. There is no financial consideration, turnover, or investment involved as of the filing date.

• · Both newly incorporated entities are classified under the real estate industry.
• · The promoters/promoter group/group companies have no interest in the new entities.

18-08-2026

J.G.Chemicals Limited announced that its material subsidiary, BDJ Oxides Private Limited, has acquired 16.74 acres of freehold land at APIIC Industrial Park in Tirupati, Andhra Pradesh, for a total consideration of Rs. 18.41 Crore (plus applicable charges). The land, located opposite BDJ Oxides' existing Naidupeta facility, will be used for future expansion of the company's sustainable recycling product portfolio. This is a strategic, long-term investment with no immediate financial impact disclosed, and no period-over-period comparisons are available.

• · The acquired land is located at Plot No. 9/2, Village Attivaram, Mondal Ozili, District Tirupati, Andhra Pradesh – 524421.
• · The land is directly opposite BDJ Oxides' existing manufacturing facility at Naidupeta, Andhra Pradesh.
• · J.G.Chemicals is India's largest Zinc Oxide manufacturer and among the top five global manufacturers, with a total zinc chemicals capacity of 70,000 MTPA.
• · The company serves 200+ domestic and 50+ global customers across more than 10 countries.
• · The company serves 9 of the top 10 global tyre manufacturers.

18-08-2026

RHI Magnesita India Limited announced that the Scheme of Merger of its wholly owned subsidiary Intermetal Engineers (India) Private Limited (turnover ₹547.44 Lakh for FY2026) into Ashwath Technologies Private Limited (turnover ₹1,737.68 Lakh for FY2026) has become effective on 18 August 2026, following approval from the Regional Director. The merger, with an appointed date of 1 April 2026, is intended to simplify the corporate structure, reduce administrative costs, and eliminate duplicate compliance. As a result, Ashwath Technologies Private Limited becomes a direct wholly owned subsidiary of RHI Magnesita India Limited, and board changes have been effected at Ashwath.

• · The appointed date of the Scheme is 1 April 2026.
• · The merger was approved under Section 233 of the Companies Act, 2013 (fast-track merger).
• · No cash consideration is involved; 10,000 equity shares of Ashwath (face value ₹10 each) will be issued to RHIMIN and its nominee.
• · Board changes at Ashwath effective 18 August 2026: Parmod Sagar and Azim Syed resigned; Pankaj Malhan (Chairman), RaviKumar Masagoundan Pudhur Periyasamy, and Abhishek Bajaj appointed as Directors.
• · The transaction is exempt from related party transaction provisions under Regulation 23(5)(b) of SEBI LODR.

18-08-2026

On August 18, 2026, Onward Technologies Limited disclosed that promoter Mrs Prachi Mehta acquired 30,127 equity shares (0.13% of paid-up capital) from the open market. The acquisition does not result in any change in control and complies with SEBI regulations. No other financial metrics or period comparisons were provided in the filing.

• · The acquisition was made from the open market, not through a preferential allotment or block deal.
• · No change in control of the company results from this transaction.
• · The filing was made under SEBI regulations for promoter share transactions.

18-08-2026

Exide Industries Limited has invested ₹1,999,999,995 (₹199.99 crore) in its wholly owned subsidiary Exide Energy Solutions Limited (EESL) to fund a greenfield lithium-ion cell manufacturing facility in Bengaluru. Total investment in EESL now stands at ₹5,102.23 crore. However, EESL reported a loss after tax of ₹248.16 crore for FY2025-26 despite a turnover of ₹157.56 crore, and its turnover declined sharply from ₹239.14 crore in FY2023-24 to ₹157.56 crore in FY2025-26.

• · EESL was incorporated on 24 March 2022 and is a wholly owned subsidiary of Exide Industries.
• · The equity shares were allotted at ₹10 each with a premium of ₹25 per share on rights basis.
• · No change in shareholding percentage (100%) after the investment.
• · The transaction is classified as a related party transaction but done at arm's length.
• · No governmental or regulatory approvals were required for the acquisition.
• · EESL's net worth as on 31 March 2026 was ₹3,991.06 crore, while paid-up equity capital was ₹1,589.93 crore.

18-08-2026

EFC (I) Limited has approved the acquisition of 100% of Ultrafresh Modular Solutions Limited (a 51% subsidiary of TTK Prestige Limited) via a share swap, issuing up to 19,99,996 equity shares as consideration. The cost of acquisition is ₹53,99,98,920 (₹53.99 Cr) for a company with a turnover of ₹36.32 Cr in FY26, ₹32.49 Cr in FY25, and ₹31.20 Cr in FY24, showing steady but modest growth. The acquisition is expected to close on or before October 31, 2026, and is intended to strengthen EFC's furniture and design & build verticals.

• · Ultrafresh is a 51% subsidiary of TTK Prestige Limited.
• · The acquisition is not a related party transaction and has been done at arm's length.
• · Ultrafresh owns a manufacturing plant at Nalagarh, Himachal Pradesh.
• · The share swap requires shareholder approval and stock exchange approval.
• · Allotment of shares is expected within 15 days of shareholder resolution, with a final completion deadline of October 31, 2026.

18-08-2026

Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has approved a share purchase agreement to acquire a 76% stake in IQGEN-X Pharma Private Limited for an aggregate consideration of approximately INR 9.12 crores, subject to adjustments. The acquisition aims to expand Alivus's end-to-end solutions in the API and CDMO space. The target company, IQGEN-X, specializes in formulation development for oral solids, sterile injectables, and ophthalmic solutions, with a turnover of INR 348 Lacs for FY 2025-26, showing consistent growth over the past three years.

• · The acquisition is not a related party transaction and no promoter has interest in the target.
• · The target company is in the pharmaceuticals industry, specializing in formulation development of Oral Solids, Sterile Injectables, and Ophthalmic solutions.
• · The acquisition is expected to complete by December 6, 2026, subject to conditions precedent.
• · If conditions precedent are not met, the sellers will enter into a Business Transfer Agreement to acquire the entire business including employees and assets.
• · No government or regulatory approvals are required for the acquisition.

18-08-2026

DLF Limited, through its material subsidiary DLF Cyber City Developers Limited (which holds ~66.67% of DLF Info Park Developers (Chennai) Limited), has agreed to acquire ~26.97% equity shares of Balang Renewables Private Limited for a cash consideration of ₹4.20 crore. The target entity, incorporated in February 2024, has nil turnover and negative net worth of ₹(0.03) crore, and the acquisition is intended to secure captive green power under the Electricity Act, 2003. The deal is small in value and the target is a pre-revenue entity, so the financial impact on DLF is minimal.

• · Target entity Balang Renewables Private Limited was incorporated on 9th February 2024.
• · The acquisition is not a related party transaction.
• · Completion expected within 30 days from execution of transaction documents.
• · No governmental or regulatory approvals are required for the acquisition.

18-08-2026

BLS International Services Limited has announced the merger of its step-down subsidiary BLS International Vize Hizmetleri Limited Sirketi (Transferor) into another step-down subsidiary, iDATA Danismanlik Ve Hizmet Dis Tic As (Transferee), effective August 17, 2026. The merger is aimed at aligning business synergies between the two visa processing entities and involves no cash consideration or change in the listed company's shareholding. The Transferor's standalone revenue was INR 167,858,678 (₹16.79 Cr) and the Transferee's was INR 1,877,772,130 (₹187.78 Cr) as of March 31, 2026, indicating a significant size disparity.

• · Effective date of merger: August 17, 2026.
• · The merger is between two step-down subsidiaries and is an arm's length related party transaction.
• · No cash consideration or share exchange ratio involved; the Transferor's share capital will be cancelled.
• · No change in shareholding pattern of the listed entity (BLS International Services Limited).
• · Both entities are in the visa processing business.

18-08-2026

OBCL Infrastructure Private Limited, a member of the promoter group of OBCL Limited (formerly Orissa Bengal Carrier Ltd.), acquired 19,181 equity shares of the company through on-market purchases on August 14, 17, and 18, 2026. The total acquisition value was approximately ₹1,035,517, increasing the promoter group's holding from 10.59% to 10.69% of the paid-up equity capital. This is a routine disclosure under SEBI insider trading regulations and represents a very small increase in promoter stake.

• · The acquisition was executed in three tranches: 297 shares on Aug 14, 216 shares on Aug 17, and 18,668 shares on Aug 18, 2026.
• · The transaction was an on-market purchase, not a preferential allotment or off-market transfer.
• · The filing is made under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, which is a routine compliance disclosure.

18-08-2026

Minal Industries Limited informed BSE that promoter and director Mr. Shrikant Jesinglal Parikh acquired 31,933 equity shares through open market transactions on August 18, 2026. His shareholding increased from 26,76,843 shares (1.39%) to 27,08,776 shares (1.41%), representing a marginal increase of 0.02% of the paid-up equity capital. The acquisition is very small in scale and does not indicate a material change in control or strategy.

• · Acquisition was made through open market transactions on August 18, 2026.
• · The increase in shareholding is only 0.02% of paid-up equity capital.
• · No consideration amount was disclosed in the filing.

18-08-2026

HEG Limited has received NCLT Indore Bench approval for a Composite Scheme of Arrangement to demerge its graphite electrode and power businesses into separate entities, and amalgamate Bhilwara Energy Limited into HEG. The scheme, sanctioned on August 13, 2026, aims to unlock shareholder value, attract focused investors, and streamline corporate structure. No financial figures or period-over-period comparisons are provided in this filing.

• · NCLT Indore Bench sanctioned the scheme on August 13, 2026; order uploaded on Tribunal website on August 18, 2026.
• · First motion application was allowed on March 26, 2026.
• · Meetings of equity shareholders, secured creditors, and unsecured creditors of HEG Limited were convened and Chairman's Reports filed.
• · Meetings of equity shareholders of Bhilwara Energy Limited were convened and Chairman's Reports filed.
• · Meetings of equity shareholders, secured creditors, and unsecured creditors of HEG Graphite Limited were dispensed with due to consent affidavits or absence of such stakeholders.
• · Scheme will become effective upon receipt of certified copy of NCLT order and filing with Registrar of Companies.
• · Board resolutions approving the scheme were dated March 10, 2025.

18-08-2026

UGRO Capital Limited has dispatched physical letters with weblinks and QR codes to equity shareholders, secured creditors, and unsecured creditors for separate meetings scheduled on September 22, 2026, to consider and approve the Scheme of Amalgamation of Profectus Capital Private Limited (PCPL) with UGRO Capital. The meetings are being convened pursuant to an order dated August 6, 2026, from the National Company Law Tribunal (NCLT), Mumbai Bench. This filing is a procedural update regarding the dispatch of meeting notices and does not contain any financial performance data.

• · The meetings will be held via video conferencing/other audio-visual means.
• · Equity shareholder meeting: September 22, 2026 at 10:30 AM IST.
• · Secured creditors meeting: September 22, 2026 at 12:15 PM IST.
• · Unsecured creditors meeting: September 22, 2026 at 2:30 PM IST.
• · Record date for equity shareholders is June 30, 2026; for secured and unsecured creditors it is March 31, 2026.
• · The Scheme is under Sections 230-232 read with Section 52 of the Companies Act, 2013.

18-08-2026

Jubilant Ingrevia Limited has entered into a binding agreement to acquire a 40% strategic stake in Zettaone Technologies India Pvt. Ltd. for ₹189.2 Cr. The acquisition, to be completed in two tranches by September 2027, aligns with the company's Pinnacle growth strategy and expands its presence into the Electronics Development and Manufacturing Services (EDMS) space. Zettaone has shown strong revenue growth, increasing from ₹51.1 Cr in FY23-24 to ₹98.1 Cr in FY25-26, though the acquisition cost represents a significant premium over current turnover.

• · The acquisition is not a related party transaction.
• · Consideration is in cash.
• · First tranche expected to close by November 2026, second tranche by September 2027.
• · Zettaone serves Aerospace, Defence, Semi-conductor, Automotive, Medical and Industrial applications.
• · Jubilant Ingrevia has over 45 years of legacy in chemicals and is among top players globally in several product categories.
• · Jubilant Ingrevia was recognized by the World Economic Forum in 2024 and entered its Global Lighthouse Network.
• · Zettaone was co-founded about two decades ago.

18-08-2026

Oxford Industries Limited has filed a Scheme of Reduction of Share Capital under Section 66 of the Companies Act, 2013, to write off accumulated losses against its capital. The company also plans to shift its registered office from Maharashtra to Odisha, subject to shareholder and regulatory approvals. No financial figures for the accumulated losses or capital reduction amounts were disclosed in the filing.

• · The company was incorporated on December 11, 1980 as L. S. Synthetics Private Limited and later renamed to Oxford Industries Limited on December 7, 1994.
• · The company's equity shares are listed on BSE (code: 514414).
• · The appointed date for the scheme is April 1, 2026, or such other date as approved by NCLT.
• · The company has proposed to shift its registered office from Maharashtra to Odisha, subject to member approval at the ensuing AGM and other statutory approvals.
• · The main objects include manufacturing and dealing in natural and synthetic fibres, textiles, readymade garments, and also operating hospitals, medicare, and pharmaceutical businesses.

18-08-2026

Repro India Limited, through its wholly owned subsidiary Repro Books Limited (RBL), has entered into a Share Purchase Agreement to acquire 100% of the equity shares of Repro LLC, a UAE-based company incorporated in July 2025 that has not yet commenced operations. The acquisition is a related party transaction (sellers are promoters/directors) and is intended to strengthen the company's presence in the UAE book distribution market. The cash consideration is AED 10,000 (approximately ₹2.2 Lakh), and completion is expected by August 31, 2026, subject to regulatory approvals from SHAMS (Sharjah Media City).

• · The acquisition is a related party transaction as the sellers, Mr. Mukesh Dhruve and Mr. Vinod Vohra, are Promoters/Directors of Repro India Limited.
• · The acquisition is proposed to be undertaken on an arm's length basis.
• · Repro LLC was incorporated on July 15, 2025, and has nil turnover since incorporation as it has not commenced business operations.
• · The Board of Directors of RBL approved the proposal on July 22, 2026, and the SPA was executed on August 18, 2026.
• · Completion is subject to share transfer formalities with SHAMS (Sharjah Media City), UAE, expected on or before August 31, 2026.

18-08-2026

Fine Organic Industries Limited has extended the timeline for completing its acquisition of an 80% stake in Oleofine Organics SDN. BHD., a Malaysian company, by an additional three months due to procedural requirements. The extension pushes the expected completion from the originally planned three-month window (ending August 2026) to November 2026, while all other terms remain unchanged.

• · The acquisition was originally announced on May 19, 2026, with a three-month completion target (by August 18, 2026).
• · Completion is now expected within the next three months from August 18, 2026, i.e., by approximately November 18, 2026.
• · The delay is attributed to unspecified procedural requirements.
• · No changes to other terms or conditions of the acquisition have been disclosed.

18-08-2026

Mrs. Jayashree Mohta, Promoter, Chairperson and Managing Director of Jay Shree Tea & Industries Ltd., acquired 1,263,485 equity shares (4.37% of voting capital) via open market purchase on August 17, 2026, increasing her total aggregate holding from 25.00% to 29.37%. The acquisition was made under the creeping acquisition route of SEBI SAST Regulations and was disclosed to the exchanges on August 18, 2026.

• · The acquisition was executed on the BSE and NSE on August 17, 2026, and intimated to the company on August 18, 2026.
• · The indirect holding via JPM Merchandise Agencies Limited remained unchanged at 6,114,108 equity shares (27.71%).
• · The total voting equity capital of the company is 28,877,488 equity shares of ₹5 each, fully paid up, and remained unchanged post-acquisition.
• · The acquisition was made under the creeping acquisition route (Regulation 3(2) of SEBI SAST Regulations, 2011).
• · The transaction value of ₹111,796,211.70 crosses the materiality thresholds under Regulation 30(4) of SEBI LODR Regulations.

18-08-2026

Piramal Pharma Limited has completed the acquisition of an additional 40.67% stake in Yapan Bio Private Limited for an aggregate cash consideration of approximately ₹76 crores, increasing its shareholding from 33.33% to 74.00%. As a result, Yapan has become a subsidiary of Piramal Pharma. Yapan's revenue from operations has been volatile, declining from ₹54.40 crores in FY2025 to ₹26.34 crores in FY2026, after growing from ₹26.91 crores in FY2024.

• · Yapan Bio was incorporated on 11th October 2019.
• · Yapan specializes in process development, characterization and Phase I/II GMP manufacturing services for vaccines and biologics.
• · The acquisition enables Piramal Pharma to embed Yapan's advanced large molecule capabilities into its integrated service offering.
• · The promoter/promoter group of Piramal Pharma is deemed indirectly interested in Yapan through the investment.

18-08-2026

Markolines Pavement Technologies Limited (MPTL) has received 'No Objection' letters from both BSE and NSE for its proposed Scheme of Amalgamation with Markolines Infra Limited (MIL), allowing the company to file the scheme with the NCLT. The observation letters, issued under Regulation 37 of SEBI LODR, include several compliance conditions such as ensuring all liabilities of MIL are transferred to MPTL, disclosing ongoing adjudication proceedings, and providing detailed financial and shareholding information to shareholders. The NSE's observation letter is valid for six months from August 17, 2026, within which the scheme must be submitted to the NCLT.

• · The NSE observation letter is valid for six months from August 17, 2026, requiring the scheme to be submitted to NCLT within that period.
• · SEBI's comments on the draft scheme include 18 specific conditions (a through r) covering compliance with LODR regulations, disclosure of ongoing adjudication, financials not older than 6 months, and mandatory demat form for any new equity shares.
• · The company must disclose the No-Objection letter on its website within 24 hours of receipt.
• · The company must complete listing and commence trading of securities within 60 days of receiving the NCLT order.
• · The exchange reserves the right to raise objections if information is found incomplete, incorrect, misleading, or false.